UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
July 1, 2025
Accession Number:
0001193125-25-153585
Submission Type:
POS AM
CIK:
0001693011
Company Name:
Inozyme Pharma, Inc.
File Number:
333-258702